MicroRNAs in platelet physiology and pathology

Hamostaseologie

Volumn 33, Issue 1, 2013, Pages 17-20

  Dangwal, S ^a   Thum, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

MicroRNAs

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; BINDING SITE; BIOGENESIS; GENE EXPRESSION; HEMOSTASIS; HUMAN; REVIEW; THROMBOCYTE; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; GENE EXPRESSION REGULATION; HEMOSTASIS; HUMANS; INFLAMMATION; MICRORNAS; PLATELET ACTIVATION;

EID: 84873584951     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.5482/HAMO-13-01-0002     Document Type: Review

References (43)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855-862.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
4. Thum T, Galuppo P, Wolf C et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 2007; 116: 258-267.
5. Fiedler J, Jazbutyte V, Kirchmaier BC et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011; 124: 720-730.
6. Thum T, Gross C, Fiedler J et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456: 980-984.
7. Ucar A, Gupta SK, Fiedler J et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nature communications 2012; 3: 1078.
8. Chen C, Ridzon DA, Broomer AJ et al. Real-time quantification of microRNAs by stem-loop RTPCR. Nucleic Acids Res 2005; 33: e179.
9. Dangwal S, Bang C, Thum T. Novel techniques and targets in cardiovascular microRNA research. Cardiovascular Res 2012; 93: 545-554.
10. Ho-Tin-Noe B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost 2011; 9 (Suppl 1): 56-65.
11. Broos K, Feys HB, De Meyer SF et al. Platelets at work in primary hemostasis. Blood Rev 2011; 25: 155-167.
12. Kottke-Marchant K. Importance of platelets and platelet response in acute coronary syndromes. Cleveland Clin J Med 2009; 76 (Suppl 1): S2-S7.
13. Boilard E, Nigrovic PA, Larabee K et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327: 580-583.
14. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011; 105 (Suppl 1): S13-S33.
15. Jain S, Harris J, Ware J. Platelets: linking hemostasis and cancer. Arterioscler Thromb Vasc Biol 2010; 30: 2362-2367.
16. Avecilla ST, Hattori K, Heissig B et al. Chemokinemediated interaction of hematopoietic progenitorswith the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10: 64-71.
17. Patel SR, Hartwig JH, Ij E. Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005; 115: 3348-3354.
18. Denis MM, Tolley ND, Bunting M et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122: 379-391.
19. Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost 2009; 7: 241-246.
20. Thon JN, Devine DV. Translation of glyco protein IIIa in stored blood platelets. Transfusion 2007; 47: 2260-2270.
21. Landry P, Plante I, Ouellet DL et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009; 16: 961-966.
22. Dittrich M, Birschmann I, Pfrang J et al. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb Haemost 2006; 95: 643-651.
23. Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular micro RNAs. Circ Res 2011; 109: 334-347.
24. Lee Y, Ahn C, Han J et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-419.
25. Gregory RI, Yan KP, Amuthan G et al. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-240.
26. Chendrimada TP, Gregory RI, Kumaraswamy E et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740-744.
27. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336-342.
28. Shyu AB, Wilkinson MF, van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J 2008; 27: 471-481.
29. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840.
30. Ple H, Landry P, Benham A et al. The repertoire and features of human platelet microRNAs. PLoS One 2012; 7: e50746.
31. Hollopeter G, Jantzen HM, Vincent D et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409: 202-207.
32. Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 2004; 113: 340-345.
33. Hechler B, Gachet C. P2 receptors and platelet function. Purinergic Signal 2011; 7: 293-303.
34. Diehl P, Fricke A, Sander L et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012; 93: 633-644.
35. Kondkar AA, Bray MS, Leal SM et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010; 8: 369-378.
36. Nagalla S, Shaw C, Kong X et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011; 117: 5189-5197.
37. Osman A, Falker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011; 22: 433-441.
38. Reid JG, Nagaraja AK, Lynn FC et al. Mouse let-7 miRNA populations exhibit RNA editing that is constrained in the 5'-seed/ cleavage/anchor regions and stabilize predicted mmu-let-7a:mRNA duplexes. Genome Res 2008; 18: 1571-1581.
39. Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res 2012; 110: 508-522.
40. Rautou PE, Vion AC, Amabile N et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593-606.
41. Sondermeijer BM, Bakker A, Halliani A et al. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340 and miRNA624. PloS one 2010; 6: e25946.
42. Girardot M, Pecquet C, Boukour S et al. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 2010; 116: 437-445.
43. Dangwal S, Thum T. MicroRNAs in platelet biogenesis and function. Thromb Haemost 2012; 108: 599-604.